Baclofen
| Baclofen | |
|---|---|
| Salts [] | |
|---|---|
| Baclofen hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 213.66 g/mol [1] |
| Melting point | 372 to 376 °F (NTP, 1992) [1] |
| Solubility | less than 1 mg/mL at 64 °F (NTP, 1992) [1] |
| Predicted LogP | -1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H12ClNO2 |
| IUPAC name | 4-amino-3-(4-chlorophenyl)butanoic acid |
| SMILES | C1=CC(=CC=C1C(CC(=O)O)CN)Cl |
| InChI | InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14) |
| InChIKey | KPYSYYIEGFHWSV-UHFFFAOYSA-N |
| CAS number | 1134-47-0 |
| UNII | H789N3FKE8 |
| PubChem CID | 2284 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 2–6 hours |
| Metabolism | 85% excreted unchanged, 15% deaminated |
| Excretion | Urine: 70–80% unchanged, 5% as metabolites |
| Routes of administration | By mouth, intrathecal, transdermal, sublingual |
| Dependence liability | Moderate–high[3] |
| Toxicity [] | |
|---|---|
| LD50 | Mouse: - Intravenous: 45 mg/kg [1] |
Baclofen (also known as Lioresal, Baclon, Kemstro, DL-Baclofen, Baclofene, Baclofeno, 4-Amino-3-(4-chlorophenyl)butyric acid, Baclofenum, Baclophen or (+-)-Baclofen) is a substance of the phenethylamine and gabapentinoid class.
Chemistry
Salts []
Stereochemistry []
Baclofen is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Baclofen matches Lipinski's rule of five.Reagents
There are currently 3 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Liebermann | no color change | |
| Froehde | no color change |
Pharmacology
ATC Classification
- musculo-skeletal system (M)
- muscle relaxants (M03)
- muscle relaxants, centrally acting agents (M03B)
- other centrally acting agents (M03BX)
- (M03BX01)
- baclofen (M03BX01)
MeSH Classification
Mechanism of action []
The exact mechanism of action of baclofen is unclear. Baclofen is an agonist at the beta subunit of gamma-aminobutyric acid (GABA) receptors expressed on pre- and post-synaptic neurons. Upon binding to GABA<sub>B</sub> receptors, baclofen causes an influx of potassium into the neuron, leading to hyperpolarization of the neuronal membrane and decreased calcium influx at presynaptic nerve terminals. This results in a decreased rate of action potential threshold being reached by presynaptic neurons and reduced action potential of postsynaptic motor neurons that innervate the muscle spindles. Baclofen thereby inhibits the transmission of both mono- and polysynaptic reflexes at the spinal cord, relaxing spasticity. Baclofen may act on some voltage-gated calcium channels; however, the clinical significance of this is unclear. [1]
Medical side effects []
211 side effects listed on drug labels in SIDER 4.1 (baclofen).
- Somnolence
- Hypotonia
- Muscle relaxant therapy
- Dizziness
- Lightheadedness
- Syncope
- Nausea
- Confusional state
- Feeling abnormal
- Malaise
- Headache
- Ataxia
- Cardiac output decreased
- Dysuria
- Urination impaired
- Enuresis
- Dermatitis
- Rash
- Gastrointestinal disorder
- Digestion impaired
- Hyperhidrosis
- Sweating increased
- Sweating
- Nightmare
- Nystagmus
- Tinnitus
- Vertigo
- Vomiting
- Fatigue
- Exhaustion
- Muscular weakness
- Accommodation disorder
- Myalgia
- Musculoskeletal discomfort
- Respiratory rate decreased
- Chest discomfort
- Dyspepsia
- Decreased appetite
- Anorexia
- Retching
- Disorientation
- Respiratory depression
- Pulmonary function test decreased
- Euphoric mood
- Personality change
- Bladder pain
- Bladder spasm
- Visual impairment
- Abnormal vision
- Sexual dysfunction
- Insomnia
- Hypotension
- Constipation
- Pollakiuria
- Vision blurred
- Convulsion
- Asthenia
- Salivary hypersecretion
- Paraesthesia
- Tingling sensation
- Hypoaesthesia
- Sensory loss
- Pruritus
- Urinary retention
- Hypoxia
- Respiratory failure
- Hypoventilation
- Lethargy
- Dysarthria
- Back pain
- Tremor
- Diarrhoea
- Urinary incontinence
- Hypertonia
- Thinking abnormal
- Mental disability
- Pain
- Speech disorder
- Alopecia
- Cerebrovascular disorder
- Dysphagia
- Dehydration
- Flushing
- Subdural haematoma
- Hypertension
- Muscle spasticity
- Pallor
- Sepsis
- Suicide attempt
- Weight decreased
- Deep vein thrombosis
- Hypogeusia
- Dysphoria
- Memory impairment
- Suicidal ideation
- Bradycardia
- Amnesia
- Ileus
- Psychotic disorder
- Paranoia
- Paranoid reaction
- Coma
- Body temperature increased
- Hallucination
- Dry mouth
- Chills
- Agitation
- Excitement
- Anxiety
- Diplopia
- Dyspnoea
- Autonomic nervous system imbalance
- Pneumonia
- Urticaria
- Injury
- Erectile dysfunction
- Arrhythmia
- Chest pain
- Osteoarthritis
- Dysgeusia
- Dyskinesia
- Haematuria
- Nasal congestion
- Nocturia
- Palpitations
- Shock
- Loss of consciousness
- Weight increased
- Hepatic function abnormal
- Drug withdrawal syndrome
- Abdominal pain
- Oedema peripheral
- Joint swelling
- Body temperature decreased
- Hypothermia
- Gastrointestinal pain
- Albuminuria
- Anaemia
- Apnoea
- Mental disorder
- Breast disorder
- Neoplasm malignant
- Infection
- Connective tissue disorder
- Depression
- Dermatitis contact
- Oedema
- Eye disorder
- Faecal incontinence
- Flatulence
- Gastroenteritis
- Gastrointestinal haemorrhage
- Cardiac disorder
- Hyperglycaemia
- Hyperventilation
- Orthostatic hypotension
- Conversion disorder
- Influenza
- Nephrolithiasis
- Leukocytosis
- Mediastinal disorder
- Meningitis
- Miosis
- Mydriasis
- Nervous system disorder
- Oliguria
- Personality disorder
- Petechiae
- Pneumonia aspiration
- Pulmonary embolism
- Renal failure
- Rhinitis
- Skin ulcer
- Cerebrovascular accident
- Completed suicide
- Swelling
- Tachycardia
- Thrombophlebitis
- Tongue disorder
- Urethral disorder
- Urinary tract disorder
- Vaginal inflammation
- Vaginal infection
- Angiopathy
- Ventricular arrhythmia
- Mood swings
- Affect lability
- Photophobia
- Musculoskeletal stiffness
- Nuchal rigidity
- Drug ineffective
- Opisthotonus
- Blood alkaline phosphatase increased
- Hyporeflexia
- Aspartate aminotransferase increased
- Malnutrition
- Skin disorder
- Discomfort
- Ill-defined disorder
- Muscle twitching
- Wound dehiscence
- Hepatobiliary disease
- Major depression
- Akathisia
- Coordination abnormal
- Face oedema
- Gait disturbance
- Cerebral ischaemia
- Haematochezia
- Ageusia
- Ejaculation disorder
Indications
- Bladder dysfunction
- Brain disorder NOS
- Brain injury
- Cerebral palsy
- Cerebrovascular disorder
- Clonus
- Epilepsy
- Head injury
- Hypertonia
- Multiple sclerosis
- Muscle rigidity
- Muscle spasms
- Muscle spasticity
- Pain
- Respiratory depression
- Spinal cord disorder
- Spinal cord injury
- Traumatic brain injury
Subjective effects []
| nervewing / Baclofen [] | |
|---|---|
Experience reports
Legal status []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 2284, Baclofen. Accessed November 22, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/2284
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Baclofen. UNII: H789N3FKE8. Global Substance Registration System. Accessed November 22, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/H789N3FKE8
Alvis BD, Sobey CM. Oral Baclofen Withdrawal Resulting in Progressive Weakness and Sedation Requiring Intensive Care Admission. The Neurohospitalist. January 2017; 7(1):39–40. PMID 28042369. https://doi.org/10.1177/1941874416637404
Product monograph brand safety updates. Health Canada. 6 June 2024. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html
Lioresal (baclofen)- baclofen kit; Lioresal (baclofen)- baclofen injection. DailyMed. 9 December 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f3bdcc0-ffc8-4911-8c35-958c8103a2c5
Ozobax- baclofen solution. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92153f69-bc9b-4bef-9a8e-751effde5c7e
Lyvispah- baclofen granule. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7d2dc58-e167-4ebc-ac1d-932f000fb412
Fleqsuvy- baclofen suspension. DailyMed. 4 February 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9076d6ce-bbc2-4a9f-9cb9-2de1b675b9aa
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:17:05 |
| drugspro | ok | 2026-11-20 07:17:01 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:17:01 |
| gsrs | ok | 2026-11-20 07:17:02 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014327) | 2026-11-20 07:17:01 |
| kegg | ok | 2026-11-20 07:17:03 |
| pubchem | ok | 2026-11-20 07:16:59 |
| ok | 2026-11-20 07:17:01 | |
| sider | ok | 2026-11-20 07:17:01 |
| structure | ok | 2026-11-20 07:17:01 |
| wikipedia | ok | 2026-11-20 07:17:01 |